ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma

NCT00352313 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

82

Enrollment

NIH

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: ATN-161
DRUG: carboplatin

Sponsor

National Institutes of Health Clinical Center (CC)

Collaborators

[object Object]